Transforming today's cancer surgery with ar
Navari have developed a unique, patent-pending technology enabling intraoperative augmented reality (AR) guidance during minimally invasive procedures. With our technology, we enhance the ability of surgeons, setting new standards for today’s cancer treatment.
introduction
From research to startup
The mission
Making this the primary choice
We are dedicated towards shaping the future of cancer treatment through minimally invasive techniques like robotic- and laparoscopic surgery. Our mission is to broaden the availability of these advanced surgical methods, which are currently underutilized despite offering substantial clinical advantages over traditional open surgery. A key obstacle to their widespread adoption is the challenge of limited visualization during these procedures, which complicates precise navigation.
The reasons
Why minimally invasive surgery?
Lower risk
A minimally invasive surgery reduces the patient’s risk of post-operative complications by 42% compared to open surgery. That is a significant difference.
Shorter stay
In average, patients undergoing minimally invasive surgery are discharged from the hospital after 4 days, compared to the 7-day average stay for open surgery.
Faster recovery
Patients who undergo minimally invasive procedures are 50% more likely to feel fully recovered after 12 months than those who undergo open surgery.
The concept
Originating from clinical need
The concept behind Navari’s technology originates from MD/PhD. Niclas Kvarnström and his daily challenges when locating- and operating cancer tumors during minimally invasive liver surgery. The limited visibility during such surgeries significantly complicates the procedures and represents a fundamental obstacle in the broader adoption of minimally invasive cancer surgery. Together with MD/Prof. Mårten Falkenberg…